Devyser Diagnostics ABFRA:OL0 77 Net Margin % is 4.69% as of Mar. 2026. GuruFocus rates FRA:OL0 with a GF Score™ of 77/100 and a GF Value™ of €14.06 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Devyser Diagnostics AB ranks better than 61.32% on this metric.
The historical rank and industry rank for Devyser Diagnostics AB's Net Margin % or its related term are showing as below:
FRA:OL0'
s Net Margin % Range Over the Past 10 Years
Min: -36.33 Med: -19.39 Max: 10.9
Current: 5.82
FRA:OL0's Net Margin % is ranked better than 61.32% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs FRA:OL0: 5.82
Devyser Diagnostics AB (FRA:OL0) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Devyser Diagnostics AB Net Margin % Related Terms
Devyser Diagnostics AB Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Devyser Diagnostics AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Devyser Diagnostics AB Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Devyser Diagnostics AB's Net Margin % distribution charts can be found below:
* The bar in red indicates where Devyser Diagnostics AB's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Devyser Diagnostics AB (FRA:OL0) has a Net Margin % of 4.69% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Devyser Diagnostics AB and its competitors. According to the industry distribution chart, Devyser Diagnostics AB ranks #316 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 38.7%.
Is Devyser Diagnostics AB's Net Margin % too high?
Devyser Diagnostics AB's current Net Margin % is 4.69%. The Medical Devices & Instruments industry median Net Margin % is 2.07. Devyser Diagnostics AB's value of 4.69% is 126.6% above this industry median. Based on the distribution chart, Devyser Diagnostics AB ranks #316 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Devyser Diagnostics AB has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Devyser Diagnostics AB's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Devyser Diagnostics AB ranks #316 out of 817 companies for Net Margin %. This puts Devyser Diagnostics AB in the upper half of its industry. The industry median Net Margin % is 2.07. Devyser Diagnostics AB's value of 4.69% is 126.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Devyser Diagnostics AB's current Net Margin % of 4.69% is 126.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Devyser Diagnostics AB and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Devyser Diagnostics AB's current Net Margin % is 4.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devyser Diagnostics AB stock overvalued right now?
Based on GuruFocus' analysis, Devyser Diagnostics AB (FRA:OL0) is currently considered Significantly Undervalued. The stock's GF Value™ is €14.06, compared to a current price of €7.59 — trading 46% below its estimated fair value. The current Net Margin % is 4.69% and 126.6% above the Medical Devices & Instruments industry median of 2.07. Devyser Diagnostics AB's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Devyser Diagnostics AB (FRA:OL0), the current Net Margin % is 4.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Devyser Diagnostics AB (FRA:OL0) Overvalued in 2026?
Based on GuruFocus' analysis, Devyser Diagnostics AB stock appears to be undervalued.
The current stock price of €7.59 is trading 46% below its estimated GF Value™ of €14.06.
GuruFocus considers Devyser Diagnostics AB to be Significantly Undervalued.
Key valuation signals for FRA:OL0:
Net Margin %: 4.69%
GF Value™: €14.06 vs. price of €7.59 (46% below fair value)
Industry Position: 126.6% above the Medical Devices & Instruments median (#316 of 817)
No single metric tells the full story. See the FRA:OL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Devyser Diagnostics AB is engaged in the development, manufacture, and sale of kits for genetic testing in routine diagnostic laboratories. The products are used for advanced genetic testing in the hereditary disease, oncology, and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.
77GF Score
Get the complete analysis for FRA:OL0
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:OL0 has been successfully added to your 
